Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: Effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260

Nephron

Volumn 76, Issue 1, 1997, Pages 111-115

  Kamoi, Kyuzi ^a  

^a NAGAOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Hyponatremia; Inappropriate antidiuresis; Selective V2 antagonist OPC 31260; Vasopressin

Indexed keywords

DEMECLOCYCLINE; MOZAVAPTAN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

AGED; ANTIDIURESIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRAVENOUS DRUG ADMINISTRATION; PLASMA OSMOLALITY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; URINE OSMOLALITY; VASOPRESSIN BLOOD LEVEL; WATER LOADING;

EID: 0030947267     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190149     Document Type: Article

References (11)

1. Swartz WB., Bennett W., Curclop S., Banter FC: A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiurctic hormone., Am J Med 1957;23:529-542.
2. Robertson GL: Cancer and inappropriate antidiuresis; in Ruddon RW (ed): Biological Markers of neoplasia: Basic and Applied Aspects., New York., Elsevier., 1978., pp 277-293.
3. Zerbe RL., Stropes L., Robertson GL: Vasopressin function in the syndrome of inappropriate antidiuresis., Annu Rev Med 1981:31:315-327.
4. Yamamura Y, Ogawa H., Yamashita H, Chilta-ra T., Miyamoto H., Nakamura S, Onodera T., Yamashita T., Hosokawa T., Mori T., Tominaga M, Yabuuchi Y: Characterization of a novel aquarct ic agent, OPC-31260, as an orally effec-tive, nonpeptide vasopressin V2 receptor antagonist., Br., I Pharmacol 1992:105:787-791.
5. Ohnishi A., Orita Y., Okahara R., Fujihara H., Inoue T., Yamamura Y., Yabuuchi Y., Tanaka T: Potent aquaretic agent: A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men., J Clin Invest 1993:92:2653-2659.
6. Kamoi K., Ebe T., Hascgawa A., Sato F, Takato H, Iwamoto H., Kaneko H., Ishibashi M., Yama-ji T: Hyponatremia in small cell lung cancer: Mechanism not involving inappropriate ADH secretion., Cancer 1987:60:1089-1093.
7. Kamoi K, Sato F, Arai O., Ishibashi M, Yamaji T: Effects of plasma volume and osmolality on secretion of atrial natriuretic peptide and vasopressin in man., Acta Endocrinol (Copenh) 1988:118:51-58.
8. Kamoi K., Ebe T., Kobayashi O., Ishida M, Sato F., Arai O., Tamura T., Takagi A, Yamada A., Ishibashi M., Yamaji T: Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretie hormone secretion and with diabetes insipidus., J Clin Endocrinol Mctab 1990:70:1385-1390.
9. Kamoi K, Tamura T., Tanaka K., Ishibashi M., Yamaji T: Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency., J Clin Endocrinol Metab 1993:77:1584-1588.
10. Kamoi K., Toyama M., Ishibashi M., Yamaji T: Hyponatremia and osmoregulation of vasopressin secretion in patients with intracranial bleeding., J Clin Endocrinol Mctab 1995: 80:2906-2911.
11. Dunger DB., Seckl JR., Lightman SL: Increased renal sensitivity to vasopressin in two patients with essential hypernatremia., J Clin Endocrinol Mctab 1987:64:185-189